Abstract: Humanized anti-A? antibodies derived from a murine antibody directed to a N-terminal epitope of A? are described. The humanized antibodies have reduced or no human T cell epitopes and bind A? with an affinity similar to that of the murine antibody.

Abstract: Humanized anti-A? antibodies derived from a murine antibody directed to a N-terminal epitope of A? are described. The humanized antibodies have reduced or no human T cell epitopes and bind A? with an affinity similar to that of the murine antibody.

Abstract: Humanized anti-A? antibodies derived from a murine antibody directed to a N-terminal epitope of A? are described. The humanized antibodies have reduced or no human T cell epitopes and bind A? with an affinity similar to that of the murine antibody.

Abstract: Humanized anti-A? antibodies derived from a murine antibody directed to a N-terminal epitope of A? are described. The humanized antibodies have reduced or no human T cell epitopes and bind A? with an affinity similar to that of the murine antibody.

Abstract: This invention relates to a device to monitor the administration of a fluid through a conduit, such as intravenous fluid, and detect the completion of fluid delivery by monitoring the fluid level inside a chamber. The device will monitor, through an optical fluid sensor comprising a radiation source, two sensors, a logic means, and an indicating means, the bottom half of any “user supplied” drip chamber that is normally full during the administration of fluids. When the fluid level in the chamber drops below a predetermined level, the indicating means will initiate an electromechanical device that releases a pinching device to occlude the conduit. The pinching device is a rotary pincher that derives its force from a torsion spring and is held in the open position by the electromechanical device.